Pratham Biotech Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.85 M
- Company Age 16 Year, 11 Months
- Last Filing with ROC 31 Mar 2021
- Open Charges ₹ 3.86 Cr
- Satisfied Charges ₹ 2.02 Cr
- Revenue Growth -4.42%
- Profit Growth -43.13%
- Ebitda 3.31%
- Net Worth 3.61%
- Total Assets 86.67%
About Pratham Biotech
Pratham Biotech Private Limited (PBPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 21 February 2008 and has a history of 16 years and 11 months. Its registered office is in Nagpur, Maharashtra, India.
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.85 M.
The company currently has active open charges totaling ₹3.86 Cr. The company has closed loans amounting to ₹2.02 Cr, as per Ministry of Corporate Affairs (MCA) records.
Sanjeev Deshmukh and Prajakta Deshmukh serve as directors at the Company.
Company Details
-
Location
Nagpur, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U74900MH2008PTC179237
-
Company No.
179237
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
21 Feb 2008
-
Date of AGM
30 Nov 2021
-
Date of Balance Sheet
31 Mar 2021
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Pratham Biotech?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sanjeev Deshmukh
|
Managing Director | 21-Feb-2008 | Current |
Board Members (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Prajakta Deshmukh
|
Whole-Time Director | 21-Feb-2008 | Current |
Financial Performance of Pratham Biotech.
Pratham Biotech Private Limited, for the financial year ended 2021, experienced Minor drop in revenue, with a 4.42% decrease. The company also saw a substantial fall in profitability, with a 43.13% decrease in profit. The company's net worth moved up by a moderate rise of 3.61%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Pratham Biotech?
In 2021, Pratham Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹38.63 M
₹20.24 M
Charges Breakdown by Lending Institutions
- Others : 3.86 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 23 Jun 2022 | Others | ₹3.00 M | Open |
| 23 Jul 2020 | Others | ₹2.78 M | Open |
| 29 Nov 2019 | Others | ₹1.30 Cr | Open |
| 29 Nov 2019 | Others | ₹1.99 Cr | Open |
| 29 Nov 2019 | Others | ₹0.14 M | Satisfied |
How Many Employees Work at Pratham Biotech?
Unlock and access historical data on people associated with Pratham Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Pratham Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pratham Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
